It was previously proposed that, like the other RASopathies, the increased predisposition of NF1 patients to develop PVS is likely related to the role of neurofibromin in the RAS–MAPK signaling pathway [30]. The gene discussed is NF1; the disease is neurofibromatosis type 1.